AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.
The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.
It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays.
The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024.
Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Country | United States |
IPO Date | Jul 24, 2013 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 82 |
CEO | Jeffrey Alan Wolf J.D. |
Contact Details
Address: 627 Davis Drive Morrisville, North Carolina United States | |
Website | https://www.scorpiusbiologics.com |
Stock Details
Ticker Symbol | SCPX |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001476963 |
CUSIP Number | n/a |
ISIN Number | US42237K4094 |
Employer ID | 26-2844103 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jeffrey Alan Wolf J.D. | Founder, Chairman, President & Chief Executive Officer |
Joe Payne | President & Chief Operating Officer of Scorpius BioManufacturing |
William L. Ostrander | Chief Financial Officer, Controller & Secretary |
Ania Szymanska | Site Head of Quality |
Colonel George E. Peoples Jr., F.A.C.S., M.D. | Chief Medical Advisor |
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. | Chief Medical Advisor and Member of Scientific & Clinical Advisory Board |
Nicole Temple | Senior Manager & Head of Program Management |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 27, 2024 | S-1 | Filing |
Dec 27, 2024 | 8-K | Current Report |
Dec 23, 2024 | 424B3 | Filing |
Dec 20, 2024 | DEF 14A | Filing |
Dec 18, 2024 | S-1 | Filing |
Dec 11, 2024 | D | Filing |
Dec 09, 2024 | PRE 14A | Filing |
Dec 06, 2024 | 8-K | Current Report |
Dec 03, 2024 | 8-K | Current Report |
Nov 14, 2024 | 10-Q | Quarterly Report |